MBED Stock Overview
The Arab Pesticides & Veterinary Drugs Mfg. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
The Arab Pesticides & Veterinary Drugs Mfg. Co. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | د.أ2.59 |
| 52 Week High | د.أ2.75 |
| 52 Week Low | د.أ2.10 |
| Beta | 0.11 |
| 1 Month Change | -3.72% |
| 3 Month Change | 5.28% |
| 1 Year Change | 21.03% |
| 3 Year Change | 7.02% |
| 5 Year Change | 78.87% |
| Change since IPO | 9.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| MBED | JO Chemicals | JO Market | |
|---|---|---|---|
| 7D | 1.2% | -1.7% | 0.7% |
| 1Y | 21.0% | -5.0% | 2.8% |
Return vs Industry: MBED exceeded the JO Chemicals industry which returned -4% over the past year.
Return vs Market: MBED exceeded the JO Market which returned 2.9% over the past year.
Price Volatility
| MBED volatility | |
|---|---|
| MBED Average Weekly Movement | 3.3% |
| Chemicals Industry Average Movement | 6.2% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in JO Market | 5.9% |
| 10% least volatile stocks in JO Market | 1.4% |
Stable Share Price: MBED has not had significant price volatility in the past 3 months compared to the JO market.
Volatility Over Time: MBED's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | n/a | Mazen Wathaifi | www.mobedco.com |
The Arab Pesticides & Veterinary Drugs Mfg. Co. PLC, together with its subsidiaries, manufactures and sells pesticides and veterinary medicines in Jordan and internationally. The company was founded in 1991 and is based in Amman, Jordan.
The Arab Pesticides & Veterinary Drugs Mfg. Co. Fundamentals Summary
| MBED fundamental statistics | |
|---|---|
| Market cap | د.أ42.74m |
| Earnings (TTM) | د.أ5.52m |
| Revenue (TTM) | د.أ33.67m |
7.7x
P/E Ratio1.3x
P/S RatioIs MBED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MBED income statement (TTM) | |
|---|---|
| Revenue | د.أ33.67m |
| Cost of Revenue | د.أ22.21m |
| Gross Profit | د.أ11.46m |
| Other Expenses | د.أ5.93m |
| Earnings | د.أ5.52m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.33 |
| Gross Margin | 34.03% |
| Net Profit Margin | 16.40% |
| Debt/Equity Ratio | 14.2% |
How did MBED perform over the long term?
See historical performance and comparisonDividends
3.9%
Current Dividend Yield29%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 11:04 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
The Arab Pesticides & Veterinary Drugs Mfg. Co. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|